Show simple item record

dc.contributor.authorAgachan, Bedia
dc.contributor.authorAydın, M
dc.contributor.authorYılmaz, F
dc.contributor.authorIsbır, Turgay
dc.date.accessioned2021-03-03T08:02:55Z
dc.date.available2021-03-03T08:02:55Z
dc.identifier.citationYılmaz F., Isbır T., Agachan B., Aydın M., "Is epsilon 4 allele of apolipoprotein E associated with more severe end-organ damage in essential hypertension?", CELL BIOCHEMISTRY AND FUNCTION, cilt.19, ss.191-195, 2001
dc.identifier.issn0263-6484
dc.identifier.othervv_1032021
dc.identifier.otherav_1562d31e-3aad-42c2-9af2-9751b616bc5c
dc.identifier.urihttp://hdl.handle.net/20.500.12627/19739
dc.description.abstractThe aim of the present study comparing patients with mild to moderate hypertension with controls, was to explore a possible association between hypertension-related target organ damage and evaluation found in the gene encoding apolipoprotein E (apo E) genotype. Detailed medical history was recorded and physical examination was per-formed for all patients in the study (88 hypertensives, 63 normotensive controls). PCR (Polymerase Chain Reaction), RFLP (Restriction Fragment Length Polymorphism), and agarose gel electrophoresis techniques were used to determine the apo E genotypes. The frequencies of apo epsilon2, apo epsilon3, and apo epsilon4 alleles were 3.97, 88.06, and 9.95%, respectively in the hypertensive group. The frequencies of apo epsilon2, apo epsilon3, and apo epsilon4 alleles were 5.5, 92.0, and 2.38%, respectively in the control group. There were about twice as many individuals in the heterozygote hypertensive group who had apo E3/4 as compared to the control group (7.30 vs. 2.38%) (p = 0.07). The hypertensive patients who were carriers of the apo epsilon4 had significantly higher organ damage (left ventricular hypertrophy (p < 0.001). dilated left atrium (p < 0.05), retinopathy (p < 0.05)) as compared to those who were not carriers of apo epsilon4. These results showed a trend for the epsilon4 allele to be associated with a higher prevalence of target organ damage in patients with mild to moderate hypertension. Copyright (C) 2001 John Wiley & Sons, Ltd.
dc.language.isoeng
dc.subjectCancer Research
dc.subjectMolecular Biology
dc.subjectDrug Discovery
dc.subjectAging
dc.subjectGeneral Biochemistry, Genetics and Molecular Biology
dc.subjectBiochemistry
dc.subjectStructural Biology
dc.subjectLife Sciences
dc.subjectHistoloji-Embriyoloji
dc.subjectHÜCRE BİYOLOJİSİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectYaşam Bilimleri
dc.subjectBİYOKİMYA VE MOLEKÜLER BİYOLOJİ
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectSitogenetik
dc.subjectTemel Bilimler
dc.subjectBiochemistry, Genetics and Molecular Biology (miscellaneous)
dc.subjectClinical Biochemistry
dc.subjectCell Biology
dc.titleIs epsilon 4 allele of apolipoprotein E associated with more severe end-organ damage in essential hypertension?
dc.typeMakale
dc.relation.journalCELL BIOCHEMISTRY AND FUNCTION
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume19
dc.identifier.startpage191
dc.identifier.endpage195
dc.contributor.firstauthorID2371516


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record